In ophthalmics, we are developing novel topical eyedrop products that target age-related diseases, including some of the largest unmet medical needs in ophthalmology.

Othera is also engaged in the discovery of a novel set of orally available compounds to address severe medical conditions including inflammatory and oncology-related diseases.